Omnipaque 350

Manufactured by Bayer

Omnipaque 350 is a nonionic, water-soluble iodinated contrast medium. It is used in various diagnostic imaging procedures to enhance the visibility of internal structures and organs.

Automatically generated - may contain errors

Lab products found in correlation

Vct 64 pet ct scanner, by GE Healthcare (1 mentions) Omnipaque, by GE Healthcare (1 mentions) Discovery st8, by GE Healthcare (1 mentions) Ge lightspeed vct 64, by GE Healthcare (1 mentions) Brilliance 64, by Philips (1 mentions)

2 protocols using omnipaque 350

Whole-body FDG PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Whole-body F-18 FDG PET/CT images were acquired using a Discovery ST 8, STE 16, RX16 or a VCT 64 PET/CT scanner (GE Healthcare, Piscataway, NJ). Patients fasted for over 6 hours, and the range of blood glucose levels was 68 to 166 mg/dl (average, 98.4 mg/dl), excluding one data point, which could not be obtained retrospectively. The average FDG dose administered was 12.3 mCi (ranging from 7.3 mCi to 19.8 mCi). Imaging from the skull vertex to the feet or proximal thighs began approximately 60–90 minutes after the intravenous administration of FDG. CT was acquired before PET with tube current modulation (mA/s) at 120 kV. The average amount of iodinated contrast (Omnipaque, GE Healthcare, Princeton, NJ) administered intravenously was 100 ml Omnipaque 350 with an automated injector (Medrad, Bayer HealthCare, Whippany, NJ) at a flow rate of 1–2.5 ml/s, based on the intravenous needle gauge and patient tolerance. All images were reconstructed with a 3.3 mm slice thickness. A breath-hold technique was not used.

Le V.T., Wong F.C., Bassett R.L, & Whitman G.J. (2020). A Comparison of the Diagnostic Value of PET/CT and Ultrasound for the Detection of Metastatic Axillary Nodal Disease in Treatment-Naive Breast Cancer. Ultrasound quarterly, 37(1), 28-33.

+ Open protocol

+ Expand

Triple-Phase CT Liver Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

All patients underwent triple-phase CT scan including unenhanced, late arterial, and portal venous phases. CT scanning was completed using one of the following scanners: (1) GE Optima 670 (GE Healthcare, Tokyo, Japan); (2) GE Lightspeed 64 VCT (GE Healthcare); (3) SIMENS SOMATOM Definition; and (4) Philips Brilliance 64 (Philips Healthcare, DA Best, the Netherlands). The following scan parameters were used: Tube voltage, 120Kvp; tube current, 200-400 mAs; helical pitch, 0.984-1.375; and 1.0 mm reconstruction slice thickness with an interval of 1.0 mm. An administration of 100-120 mL nonionic contrast media (Omnipaque 350, Bayer Pharmaceuticals) at a rate of 3.0-4.0 mL/s was performed after the unenhanced CT scan. The late arterial and portal venous phases were acquired at 35 s and 70 s, respectively.

Ren S., Qian L.C., Cao Y.Y., Daniels M.J., Song L.N., Tian Y, & Wang Z.Q. (2024). Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology, 16(4), 1256-1267.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!